QR link for World Health Organization : Year 2003 ; The Special Programme for Research and Training in Tropical Diseases Swg 02: Report of the Scientific Working Groupmeeting on Leprosy
Add to Book Shelf
Flag as Inappropriate
Email this Book

World Health Organization : Year 2003 ; The Special Programme for Research and Training in Tropical Diseases Swg 02: Report of the Scientific Working Groupmeeting on Leprosy

By World Health Organization

Click here to view

Book Id: WPLBN0000155720
Format Type: PDF eBook
File Size: 1.9 MB
Reproduction Date: 2005

Title: World Health Organization : Year 2003 ; The Special Programme for Research and Training in Tropical Diseases Swg 02: Report of the Scientific Working Groupmeeting on Leprosy  
Author: World Health Organization
Volume:
Language: English
Subject: Health., Public health, Wellness programs
Collections: Medical Library Collection, World Health Collection
Historic
Publication Date:
Publisher: World Health Organization

Citation

APA MLA Chicago

Organization, W. H. (n.d.). World Health Organization : Year 2003 ; The Special Programme for Research and Training in Tropical Diseases Swg 02. Retrieved from http://cn.ebooklibrary.org/


Description
Medical Reference Publication

Excerpt
1. Executive summary In 1977, the World Health Organization (WHO) Expert Committee on Leprosy estimated the global number of leprosy cases to be over 12 million. In 1981, WHO convened the Study Group on Chemotherapy for Leprosy Control, which recommended combined-drug regimens based on supervised intermittent administration of rifampicin for both multibacillary (MB) and paucibacillary (PB) leprosy. Thanks to the implementation of this multidrug therapy (MDT), substantial progress in leprosy control has been achieved and over 12 million cases had been cured by 2002. However, to date there is no clear evidence of an impact of introduction of MDT on the rate of detection of new cases. Approaches to address this question are impeded by a lack of fundamental knowledge about the epidemiology of leprosy, the sources of infection, its precise mode of transmission and the importance of contact patterns. Worldwide, and in spite of the dramatic impact of MDT on leprosy prevalence, 2-3 million people are still living with deformities due to leprosy. As new cases remain at risk of developing nerve impairment, detecting, managing and understanding the mechanism(s) involved in nerve damage remain a high priority for research programmes. Studies to date have not provided the optimal approaches needed to assure the prevention and management of nerve impairment.

Table of Contents
Contents 1. Executive summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1 2. Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3 3. Rationale for the Scientific Working Group . . . . . . . . . . . . . . . . . . . . . . . . . . . .4 4. Goals, objectives and expected outcomes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5 5. Partners . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .6 6. Meeting report . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7 MAJOR CHALLENGES AND PRIORITY RESEARCH NEEDS . . . . . . . . . . . . . . . . . . . . . . . . . . .7 ONGOING GLOBAL RESEARCH EFFORTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .8 RESEARCH OPPORTUNITIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9 Transmission/diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .9 Nerve damage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Research to improve integration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 Cross-cutting issues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 7. Next steps . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Annex 1 AGENDA: SCIENTIFIC WORKING GROUP ON LEPROSY . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 Annex 2 LIST OF PARTICIPANTS: SCIENTIFIC WORKING GROUP ON LEPROSY . . . . . . . . . . . . . . . . . 17 Annex 3 WORKING PAPER: SOCIAL, PSYCHOLOGICAL AND BEHAVIOURAL RESEARCH IN LEPROSY . . . 21 Annex 4 WORKING PAPER: CHEMOTHERAPY AND CHEMOPROPHYLAXIS OF LEPROSY . . . . . . . . . . . . . 27 Annex 5 WORKING PAPER: LEPROSY – NEW OPPORTUNITIES IN BASIC SCIENCE . . . . . . . . . . . . . . . . 35 Annex 6 WORKING PAPER: THE IMPACT OF MULTIDRUG THERAPY ON TRENDS IN TRANSMISSION . . . . 41


 
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.